Document is current
Any future updates will be listed below
-
Authors
Ball, Lorenzo https://orcid.org/0000-0002-3876-4730
Robba, Chiara
Herrmann, Jacob
Gerard, Sarah E.
Xin, Yi
Mandelli, Maura
Battaglini, Denise
Brunetti, Iole
Minetti, Giuseppe
Seitun, Sara
Bovio, Giulio
Vena, Antonio
Giacobbe, Daniele Roberto
Bassetti, Matteo
Rocco, Patricia R. M.
Cereda, Maurizio
Rizi, Rahim R.
Castellan, Lucio
Patroniti, Nicolò
Pelosi, Paolo
,
Bixio, Mattia
Gratarola, Angelo
Frisoni, Paolo
Loconte, Maurizio
Molin, Alexandre
Orefice, Giulia
Ciaravolo, Elena
Costantino, Federico
Battioni, Dario
Buconte, Gerolama
Casaleggio, Alessandro
Cittadini, Giuseppe
Dogliotti, Luca
Giasotto, Veronica
Perissi, Sara
Pigati, Maria
Santacroce, Elena
Zaottini, Federico
Dentone, Chiara
Taramasso, Lucia
Magnasco, Laura
Bastianello, Matilde
-
Funding
Funding for this research was provided by:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (421067/2016-0)
Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (E-26/210.181/2020)
- License Information
-
More Information
Article History
Received: 2 March 2021
Accepted: 19 May 2021
First Online: 21 June 2021
Declarations
:
: The ethics review board approved the protocol of the study (Comitato Etico Regione Liguria, protocol n. 163/2020). The need for written informed consent was waived for retrospectively collected data. According to local regulations, consent was delayed after discharge for prospectively collected data in unconscious patients.
: Not applicable.
: Dr. Bassetti reports personal fees and other from Angelini, personal fees and other from AstraZeneca, other from Bayer, personal fees and other from Cubist, personal fees and other from Pfizer, personal fees and other from Menarini, personal fees and other from MSD, other from Nabriva, other from Paratek, other from Roche, other from Shionogi, other from Tetraphase, other from The Medicine Company, personal fees and other from Astellas Pharma Inc., personal fees from Gilead Sciences, personal fees from Teva, personal fees from Novartis, grants from Ranbaxy, personal fees from Correvio, personal fees from Molteni, personal fees from Thermo Fisher, outside the submitted work. Dr. Herrmann is a cofounder and shareholder of OscillaVent, Inc, and consultant for ZOLL Medical Corporation, both outside the submitted work. Dr. Giacobbe reports personal fees from Stepstone Pharma GmbH, personal fees from MSD Italia, personal fees from Correvio Italia, outside the submitted work. Dr. Rocco reports personal fees from SANOFI as a DSMB member. All other authors declared no conflict of interest.
